ZTE, the Chinese telecom firm, may see losses of as much as US$3.1 billion amid a continuing ban from the US government on US firms supplying components and materials to ZTE.
The estimates came Wednesday morning, May 23, from Bloomberg, which cited unnamed sources.
Bloomberg also reported that ZTE remains “hopeful” that its home country, China, and the United States will be able to strike a deal to break that ban. Once that happens, ZTE will be able to start up factories that have remained dark in the wake of the ban.
Separately, Reuters also reported that President Donald Trump on Tuesday “floated a plan” to fine the Chinese tech firm and “shake up its management” even as the Trump administration is considering scaling back some of the more severe penalties in place that have, at least in part, led to the financial impact and losses as mentioned above.
The proposal is getting pushback from Congress, and across both parties, as critics charge Trump is, as Reuters termed that criticism, “bending to pressure” from China even as the company has admitted to skirting sanctions the US has in place on Iran.
Trump has said that US tech firms had been hurt by a Commerce Department mandate from last month stating that those firms cannot sell components to ZTE. Trump had suggested that the firm be hit with a US$1.3 billion fine, and a shakeup of management and its board of directors. Reuters stated that “it was not clear whether he had the legal authority to impose new financial penalties.”
Trump said: “They can pay a big price without necessarily damaging all of these American companies.”
Full Content: PYMNTS
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas